Session 2: Harmonization of NAMs — Can it really be global? (in English)

For our first session on defining criteria for the regulatory acceptance of NAMs, we had the honor and pleasure to welcome Dr Carl Westmoreland (Unilever), Pr Ellen Fritsche (DNTOX & SCAHT) and Dr Clive Roper for what has been a fascinating and fruitful discussion.

For this session 2, we wanted to explore and discuss current challenges, opportunities, and ongoing actions in favor of harmonizing NAMs, to ensure it can and will be regulated / accepted worldwide, and under the same criteria. We had the privilege to welcome Dr Nicole Kleinstreuer, NICEATM Director at National Institute of Environmental Health Sciences (NIEHS), Dr Nina Hobi, CEO at AlveoliX and Dr Surat Parvatam, Senior Strategist at HSI India.

We also were delighted to moderate the session with Prof Merel Ritskes-Hoitinga, from the University of Utrecht.